The Care Continuum: Veracyte’s CEO on its Diagnostic Strategy
Opto Sessions – Invest in the Next Big Idea
00:00
Navigating Genomics: A Transition from Finance to Cancer Care
This chapter explores the compelling journey of an individual who transitioned from the finance sector to the genomics field, emphasizing their significant role at Illumina and insights gained from operational leadership at Helix during the pandemic. It highlights the evolving landscape of molecular diagnostics, including struggles and strategic focuses of companies, particularly in cancer care. The discussion also covers the integration of AI and advanced technologies in enhancing diagnostic processes, showcasing the promise of innovative solutions in patient care.
Transcript
Play full episode
